# Effects of Phosphatidylserine and DHA on Cognitive Performance in Children With ADHD

> **NCT07521449** · NA · COMPLETED · sponsor: **Çağlar Charles Daniel Jaicks** · enrollment: 45 (actual)

## Conditions studied

- Attention Deficit Hyperactivity Disorder (ADHD)
- ADHD

## Interventions

- **OTHER:** Placebo
- **DIETARY_SUPPLEMENT:** Phosphatidylserine-Omega3
- **DIETARY_SUPPLEMENT:** Phosphatidylserine-Omega3
- **DIETARY_SUPPLEMENT:** DHA Omega-3

## Key facts

- **NCT ID:** NCT07521449
- **Lead sponsor:** Çağlar Charles Daniel Jaicks
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-30
- **Primary completion:** 2024-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07521449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07521449, "Effects of Phosphatidylserine and DHA on Cognitive Performance in Children With ADHD". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT07521449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*